Chronic Heart Failure Clinical Trial
Official title:
The Effect of Kinesio Taping Method and Breathing Exercises on Pulmonary Function, Respiratory Muscle Strength, Functional Capacity and Quality of Life in Patients With Chronic Heart Failure
This randomised controlled study investigates the effect of Kinesio Taping on pulmonary function, respiratory muscle strength, functional capacity, functional mobility, hand grip strength, quality of life and level of depression in patients with chronic heart failure (CHF). The study also compares effects of Kinesio Taping and Inspiratory Muscle Training (IMT). There were 3 study groups: The experimental group received Kinesio Taping; the breathing exercise group received IMT; and the control group received no interventions.
Individuals with chronic heart failure (CHF) have been found to have poor respiratory muscle
strength and endurance. The reduction of respiratory muscle strength may be a sign of
increased work of breathing in CHF. Exercise intolerance and dyspnea are common symptoms of
patients with CHF and are relevant with a poor functional capacity and quality of life. The
primary aim of cardiac rehabilitation programs for CHF patients is to increase their exercise
tolerance and quality of life. Patients with CHF have decreased lung volume, increased work
of breathing, and greater oxygen consumption. Pulmonary rehabilitation may improve quality of
life and exercise capacity in patients with CHF. It has been shown that inspiratory muscle
training is beneficial for improving respiratory muscle strength, functional capacity, and
dyspnea in patients with stable heart failure and respiratory muscle weakness.
It has been found that inspiratory muscle training (IMT) results in improvement in
inspiratory muscle strength, functional capacity and quality of life of patients with CHF and
inspiratory muscle weakness. Previous studies have shown that the diaphragm has circulatory
functions in addition to its better known respiratory functions, that diaphragm strength and
endurance diminish in CHF.
Kinesio taping is a relatively new bandaging technique usually applied to normalize muscle
function, increase lymph and blood circulation, decrease pain and/or aid the correction of
joint misalignment. In literature there are several studies demonstrating results of
inspiratory muscle training on pulmonary function in patients with CHF. But we haven't found
any studies demonstrating effects of kinesio taping on respiratory mechanics and exercise
capacity in patients with CHF. The study we designed therefore may contribute to the
literature and may inform future studies.We hypothesized that KT methods used for respiratory
muscles would be effective on improving pulmonary function, respiratory muscle strength,
quality of life, functional capacity of CHF patients.
Clinically stable 57 CHF patients with New York Heart Association (NYHA) functional class
II-III, between the ages 43 and 89 participated in the study. All participants were recruited
between September 2016 and February 2017. All the assessments and treatments were performed
in the same hospital, Istanbul University Institution of Cardiology, by the same person. The
experimental group received Kinesio Taping; the breathing exercise group received IMT; and
the control group received no interventions. The Kinesio Taping group received KT
facilitation technique for musculus diaphragmaticus (ventral and dorsal parts) and for
musculus obliquus internus-externus abdominis (bilateral) to improve inspiratory and forced
expiratory muscle activity, respectively. KT was applied twice a week during a 4-week period.
By combination of these muscle techniques we investigated the changes in pulmonary functions,
respiratory muscle strength, functional exercise capacity, functional mobility, hand grip
strength, quality of life and level of depression. All the assessments were performed at
baseline and four weeks after treatment.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT04065997 -
Apogee International
|
||
Withdrawn |
NCT03675113 -
Effect of Upper Extremity Aerobic Exercise Training on Exercise Capacity Patients With Chronic Heart Failure
|
N/A | |
Completed |
NCT02916160 -
Sacubitril-valsartan and Heart Failure Patients : the ENTRESTO-SAS Study
|
Phase 4 | |
Completed |
NCT03126656 -
Effects of Testosterone on Myocardial Repolarization
|
Phase 4 | |
Completed |
NCT02247245 -
The Influence of Heart Rate Limitation on Exercise Tolerance in Pacemaker Patients.
|
N/A | |
Completed |
NCT02268500 -
VAccination to Improve Clinical outComes in Heart Failure Trial: a Feasibility Study (VACC-HeFT)
|
Phase 4 | |
Completed |
NCT01919918 -
Muscle Afferent Feedback Effects in Patients With Heart Failure
|
Phase 1 | |
Terminated |
NCT01906957 -
Cognition and Exercise Training
|
N/A | |
Not yet recruiting |
NCT01669395 -
Severe Heart Failure and Homebased Rehabilitation - An Intersectoral Randomized Controlled Trial
|
N/A | |
Completed |
NCT00984529 -
Evaluation of Clinical Signs and Symptoms of Chronic Heart Failure in Patients Treated With Candesartan Cilexetil in Croatia
|
N/A | |
Recruiting |
NCT00863421 -
Sleep Disordered Breathing in Patients With Chronic Heart Failure
|
N/A | |
Completed |
NCT02840565 -
Tolerability, Pharmacokinetics and Pharmacodynamics of Six Multiple Rising Dose Regimens of BIA 5-453
|
Phase 1 | |
Completed |
NCT02441218 -
Effects of Ivabradine on Cardiovascular Events in Patients With Moderate to Severe Chronic Heart Failure and Left Ventricular Systolic Dysfunction. A Three-year International Multicentre Study
|
Phase 3 | |
Completed |
NCT00149409 -
Omega-3-Polyunsaturated Fatty-Acids (N3-Pufa) In Patients With Severe Chronic Heart Failure
|
Phase 2/Phase 3 | |
Terminated |
NCT05532046 -
A Study to Learn How Safe Study Drug BAY2413555 is, How it Affects the Body, and How it Moves Into, Through, and Out of the Body Over 4 Weeks of Use in Participants With Heart Failure and Implanted Cardiac Defibrillator or Cardiac Resynchronization Devices (ICD/CRT)
|
Phase 1 | |
Recruiting |
NCT04984928 -
Readmission Risk of Patients With Heart Failure.
|
||
Completed |
NCT02814097 -
A Study to Evaluate the Effects of 4 Weeks Treatment With Subcutaneous Elamipretide on Left Ventricular Function in Subjects With Stable Heart Failure With Preserved Ejection Fraction
|
Phase 2 | |
Active, not recruiting |
NCT05560737 -
ODYSSEE-vCHAT Mental Health Program for Heart Failure and Kidney Disease Patients
|
||
Recruiting |
NCT03286127 -
Palliative Outcome Evaluation Muenster I
|
||
Not yet recruiting |
NCT06002321 -
Right Ventricular Dysfunction in Chronic Heart Failure
|